[HTML][HTML] The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion …
J Wu, H Zhang, Y Zheng, X Jin, M Liu, S Li… - Frontiers in …, 2018 - frontiersin.org
By shaping T cell immunity, tolerogenic dendritic cells (tDCs) play critical roles in the
induction of immune tolerance after transplantation. However, the role of long noncoding …
induction of immune tolerance after transplantation. However, the role of long noncoding …
Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune tolerance
The intravenous delivery of disease-relevant antigens (Ag) by polymeric nanoparticles (NP-
Ags) has demonstrated Ag-specific immune tolerance in autoimmune and allergic disorders …
Ags) has demonstrated Ag-specific immune tolerance in autoimmune and allergic disorders …
Overcoming challenges in treating autoimmuntity: development of tolerogenic immune-modifying nanoparticles
Autoimmune diseases, such as celiac disease, multiple sclerosis, and type 1 diabetes, are
leading causes of morbidity and mortality in the United States. In these disease states …
leading causes of morbidity and mortality in the United States. In these disease states …
Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation
Developing biomaterials to control the responsiveness of innate immune cells represents a
clinically relevant approach to treat diseases with an underlying inflammatory basis, such as …
clinically relevant approach to treat diseases with an underlying inflammatory basis, such as …
[HTML][HTML] Controlled delivery of single or multiple antigens in tolerogenic nanoparticles using peptide-polymer bioconjugates
RM Pearson, LM Casey, KR Hughes, LZ Wang… - Molecular Therapy, 2017 - cell.com
Polymeric nanoparticles (NPs) have demonstrated their potential to induce antigen (Ag)-
specific immunological tolerance in multiple immune models and are at various stages of …
specific immunological tolerance in multiple immune models and are at various stages of …
Designing natural and synthetic immune tissues
EA Gosselin, HB Eppler, JS Bromberg, CM Jewell - Nature materials, 2018 - nature.com
Vaccines and immunotherapies have provided enormous improvements for public health,
but there are fundamental disconnects between where most studies are performed—in cell …
but there are fundamental disconnects between where most studies are performed—in cell …
[HTML][HTML] Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
Cancer virotherapy is a paradigm-shifting treatment modality based on virus-mediated
oncolysis and subsequent antitumor immune responses. Clinical trials of currently available …
oncolysis and subsequent antitumor immune responses. Clinical trials of currently available …
Transdermal immunomodulation: Principles, advances and perspectives
Immunomodulation, manipulation of the immune responses towards an antigen, is a
promising strategy to treat cancer, infectious diseases, allergies, and autoimmune diseases …
promising strategy to treat cancer, infectious diseases, allergies, and autoimmune diseases …
[HTML][HTML] Immunomodulatory nanoparticles mitigate macrophage inflammation via inhibition of PAMP interactions and lactate-mediated functional reprogramming of NF …
JJM Lasola, AL Cottingham, BL Scotland, N Truong… - Pharmaceutics, 2021 - mdpi.com
Inflammation is a key homeostatic process involved in the body's response to a multitude of
disease states including infection, autoimmune disorders, cancer, and other chronic …
disease states including infection, autoimmune disorders, cancer, and other chronic …
Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide-co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance
LM Casey, RM Pearson, KR Hughes… - Bioconjugate …, 2017 - ACS Publications
Current strategies for treating autoimmunity involve the administration of broad-acting
immunosuppressive agents that impair healthy immunity. Intravenous (iv) administration of …
immunosuppressive agents that impair healthy immunity. Intravenous (iv) administration of …